{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:59Z","timestamp":1786980119521,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Clinical Research Center For Medical Imaging In Hunan Province","award":["2020SK4001"],"award-info":[{"award-number":["2020SK4001"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61971451"],"award-info":[{"award-number":["61971451"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovative Province special construction foundation of Hunan Province","award":["2019SK2131"],"award-info":[{"award-number":["2019SK2131"]}]},{"name":"the science and technology innovation program of hunan province","award":["2021RC4016"],"award-info":[{"award-number":["2021RC4016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00406-023-01613-x","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T09:02:22Z","timestamp":1683277342000},"page":"453-459","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The genetic susceptibility analysis of TAAR1 rs8192620 to methamphetamine and heroin abuse and its role in impulsivity"],"prefix":"10.1007","volume":"274","author":[{"given":"Fei","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longtao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"1613_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.biopsych.2020.08.005","volume":"89","author":"CT Werner","year":"2021","unstructured":"Werner CT, Altshuler RD, Shaham Y, Li X (2021) Epigenetic mechanisms in drug relapse. Biol Psychiatry 89:331\u2013338. https:\/\/doi.org\/10.1016\/j.biopsych.2020.08.005","journal-title":"Biol Psychiatry"},{"key":"1613_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/npp.2013.261","volume":"39","author":"RA Wise","year":"2014","unstructured":"Wise RA, Koob GF (2014) The development and maintenance of drug addiction. Neuropsychopharmacology 39:254\u2013262. https:\/\/doi.org\/10.1038\/npp.2013.261","journal-title":"Neuropsychopharmacology"},{"key":"1613_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000506868","volume":"89","author":"F Cosci","year":"2020","unstructured":"Cosci F, Chouinard G (2020) Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications. Psychother Psychosom 89:283\u2013306. https:\/\/doi.org\/10.1159\/000506868","journal-title":"Psychother Psychosom"},{"key":"1613_CR4","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.3389\/fimmu.2019.02904","volume":"10","author":"TK Eisenstein","year":"2019","unstructured":"Eisenstein TK (2019) The role of opioid receptors in immune system function. Front Immunol 10:2904. https:\/\/doi.org\/10.3389\/fimmu.2019.02904","journal-title":"Front Immunol"},{"issue":"Suppl 1","key":"1613_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1360-0443.2007.01771.x","volume":"102","author":"TJ Volz","year":"2007","unstructured":"Volz TJ, Fleckenstein AE, Hanson GR (2007) Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment. Addiction 102(Suppl 1):44\u201348. https:\/\/doi.org\/10.1111\/j.1360-0443.2007.01771.x","journal-title":"Addiction"},{"key":"1613_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev-psych-010418-103337","volume":"71","author":"RA Wise","year":"2020","unstructured":"Wise RA, Robble MA (2020) Dopamine and addiction. Annu Rev Psychol 71:79\u2013106. https:\/\/doi.org\/10.1146\/annurev-psych-010418-103337","journal-title":"Annu Rev Psychol"},{"key":"1613_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuro.2017.09.006","volume":"63","author":"NB Miner","year":"2017","unstructured":"Miner NB, Elmore JS, Baumann MH et al (2017) Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity. Neurotoxicology 63:57\u201369. https:\/\/doi.org\/10.1016\/j.neuro.2017.09.006","journal-title":"Neurotoxicology"},{"key":"1613_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1017\/S1461145713001302","volume":"17","author":"K Toriumi","year":"2014","unstructured":"Toriumi K, Kondo M, Nagai T et al (2014) Deletion of SHATI\/NAT8L increases dopamine D1 receptor on the cell surface in the nucleus accumbens, accelerating methamphetamine dependence. Int J Neuropsychopharmacol 17:443\u2013453. https:\/\/doi.org\/10.1017\/S1461145713001302","journal-title":"Int J Neuropsychopharmacol"},{"key":"1613_CR9","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.3892\/etm.2017.5615","volume":"15","author":"H Ji","year":"2018","unstructured":"Ji H, Xu X, Liu G et al (2018) Dopamine receptor D4 promoter hypermethylation increases the risk of drug addiction. Exp Ther Med 15:2128\u20132133. https:\/\/doi.org\/10.3892\/etm.2017.5615","journal-title":"Exp Ther Med"},{"key":"1613_CR10","first-page":"147","volume":"45","author":"T Koseki","year":"2010","unstructured":"Koseki T, Nabeshima T (2010) Drug addiction research using intravenous self-administration procedure in mice. Nihon Arukoru Yakubutsu Igakkai Zasshi 45:147\u2013156","journal-title":"Nihon Arukoru Yakubutsu Igakkai Zasshi"},{"key":"1613_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/bs.irn.2016.02.001","volume":"126","author":"TJ Phillips","year":"2016","unstructured":"Phillips TJ, Mootz JRK, Reed C (2016) Identification of treatment targets in a genetic mouse model of voluntary methamphetamine drinking. Int Rev Neurobiol 126:39\u201385. https:\/\/doi.org\/10.1016\/bs.irn.2016.02.001","journal-title":"Int Rev Neurobiol"},{"key":"1613_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.schres.2017.02.020","volume":"189","author":"J John","year":"2017","unstructured":"John J, Kukshal P, Bhatia T et al (2017) Possible role of rare variants in trace amine associated receptor 1 in schizophrenia. Schizophr Res 189:190\u2013195. https:\/\/doi.org\/10.1016\/j.schres.2017.02.020","journal-title":"Schizophr Res"},{"key":"1613_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fphar.2018.00329","volume":"9","author":"I Sukhanov","year":"2018","unstructured":"Sukhanov I, Dorofeikova M, Dolgorukova A et al (2018) Trace amine-associated receptor 1 modulates the locomotor and sensitization effects of nicotine. Front Pharmacol 9:329. https:\/\/doi.org\/10.3389\/fphar.2018.00329","journal-title":"Front Pharmacol"},{"key":"1613_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fnins.2015.00039","volume":"9","author":"R Cotter","year":"2015","unstructured":"Cotter R, Pei Y, Mus L et al (2015) The trace amine-associated receptor 1 modulates methamphetamine\u2019s neurochemical and behavioral effects. Front Neurosci 9:39. https:\/\/doi.org\/10.3389\/fnins.2015.00039","journal-title":"Front Neurosci"},{"key":"1613_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejphar.2015.06.026","volume":"763","author":"VM Lam","year":"2015","unstructured":"Lam VM, Espinoza S, Gerasimov AS et al (2015) In-vivo pharmacology of trace-amine associated receptor 1. Eur J Pharmacol 763:136\u2013142. https:\/\/doi.org\/10.1016\/j.ejphar.2015.06.026","journal-title":"Eur J Pharmacol"},{"key":"1613_CR16","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/j.1601-183X.2006.00292.x","volume":"6","author":"TD Wolinsky","year":"2007","unstructured":"Wolinsky TD, Swanson CJ, Smith KE et al (2007) The trace amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia. Genes Brain Behav 6:628\u2013639. https:\/\/doi.org\/10.1111\/j.1601-183X.2006.00292.x","journal-title":"Genes Brain Behav"},{"key":"1613_CR17","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1124\/jpet.109.153775","volume":"330","author":"Z Xie","year":"2009","unstructured":"Xie Z, Miller GM (2009) A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain. J Pharmacol Exp Ther 330:316\u2013325. https:\/\/doi.org\/10.1124\/jpet.109.153775","journal-title":"J Pharmacol Exp Ther"},{"key":"1613_CR18","doi-asserted-by":"publisher","first-page":"593146","DOI":"10.3389\/fneur.2020.593146","volume":"11","author":"IE Cisneros","year":"2020","unstructured":"Cisneros IE, Ghorpade A, Borgmann K (2020) Methamphetamine activates trace amine associated receptor 1 to regulate astrocyte excitatory amino acid transporter-2 via differential CREB phosphorylation during HIV-associated neurocognitive disorders. Front Neurol 11:593146. https:\/\/doi.org\/10.3389\/fneur.2020.593146","journal-title":"Front Neurol"},{"key":"1613_CR19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.neuropharm.2014.06.011","volume":"85","author":"IE Cisneros","year":"2014","unstructured":"Cisneros IE, Ghorpade A (2014) Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes. Neuropharmacology 85:499\u2013507. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.06.011","journal-title":"Neuropharmacology"},{"key":"1613_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fnins.2015.00327","volume":"9","author":"TJ Phillips","year":"2015","unstructured":"Phillips TJ, Shabani S (2015) An animal model of differential genetic risk for methamphetamine intake. Front Neurosci 9:327. https:\/\/doi.org\/10.3389\/fnins.2015.00327","journal-title":"Front Neurosci"},{"key":"1613_CR21","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1111\/bph.15061","volume":"177","author":"J Liu","year":"2020","unstructured":"Liu J, Johnson B, Wu R et al (2020) TAAR1 agonists attenuate extended-access cocaine self-administration and yohimbine-induced reinstatement of cocaine-seeking. Br J Pharmacol 177:3403\u20133414. https:\/\/doi.org\/10.1111\/bph.15061","journal-title":"Br J Pharmacol"},{"key":"1613_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neuropharm.2017.11.012","volume":"129","author":"Z Xue","year":"2018","unstructured":"Xue Z, Siemian JN, Johnson BN et al (2018) Methamphetamine-induced impulsivity during chronic methamphetamine treatment in rats: effects of the TAAR 1 agonist RO5263397. Neuropharmacology 129:36\u201346. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.11.012","journal-title":"Neuropharmacology"},{"key":"1613_CR23","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/npp.2015.61","volume":"40","author":"JH Harkness","year":"2015","unstructured":"Harkness JH, Shi X, Janowsky A, Phillips TJ (2015) Trace amine-associated receptor 1 regulation of methamphetamine intake and related traits. Neuropsychopharmacology 40:2175\u20132184. https:\/\/doi.org\/10.1038\/npp.2015.61","journal-title":"Neuropsychopharmacology"},{"key":"1613_CR24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.tics.2015.06.007","volume":"19","author":"Y-Y Tang","year":"2015","unstructured":"Tang Y-Y, Posner MI, Rothbart MK, Volkow ND (2015) Circuitry of self-control and its role in reducing addiction. Trends Cogn Sci 19:439\u2013444. https:\/\/doi.org\/10.1016\/j.tics.2015.06.007","journal-title":"Trends Cogn Sci"},{"key":"1613_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/bs.acc.2016.11.002","volume":"80","author":"K Matsuda","year":"2017","unstructured":"Matsuda K (2017) PCR-based detection methods for single-nucleotide polymorphism or mutation: real-time PCR and its substantial contribution toward technological refinement. Adv Clin Chem 80:45\u201372. https:\/\/doi.org\/10.1016\/bs.acc.2016.11.002","journal-title":"Adv Clin Chem"},{"key":"1613_CR26","doi-asserted-by":"publisher","first-page":"e0220270","DOI":"10.1371\/journal.pone.0220270","volume":"14","author":"JM Loftis","year":"2019","unstructured":"Loftis JM, Lasarev M, Shi X et al (2019) Trace amine-associated receptor gene polymorphism increases drug craving in individuals with methamphetamine dependence. PLoS\u00a0One 14:e0220270. https:\/\/doi.org\/10.1371\/journal.pone.0220270","journal-title":"PLoS\u00a0One"},{"key":"1613_CR27","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1038\/s41598-020-80089-4","volume":"11","author":"KA Samara","year":"2021","unstructured":"Samara KA, Barqawi HJ, Aboelsoud BH et al (2021) Hepatitis A virus knowledge and immunization attitudes and practices in the United Arab Emirates community. Sci Rep 11:2651. https:\/\/doi.org\/10.1038\/s41598-020-80089-4","journal-title":"Sci Rep"},{"key":"1613_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.comppsych.2015.02.017","volume":"59","author":"H Su","year":"2015","unstructured":"Su H, Tao J, Zhang J et al (2015) The analysis of BDNF gene polymorphism haplotypes and impulsivity in methamphetamine abusers. Compr Psychiatry 59:62\u201367. https:\/\/doi.org\/10.1016\/j.comppsych.2015.02.017","journal-title":"Compr Psychiatry"},{"key":"1613_CR29","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1038\/npp.2015.65","volume":"40","author":"S Espinoza","year":"2015","unstructured":"Espinoza S, Lignani G, Caffino L et al (2015) TAAR1 modulates cortical glutamate NMDA receptor function. Neuropsychopharmacology 40:2217\u20132227. https:\/\/doi.org\/10.1038\/npp.2015.65","journal-title":"Neuropsychopharmacology"},{"key":"1613_CR30","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.euroneuro.2012.08.016","volume":"23","author":"M Corominas-Roso","year":"2013","unstructured":"Corominas-Roso M, Roncero C, Eiroa-Orosa FJ et al (2013) Brain-derived neurotrophic factor serum levels in cocaine-dependent patients during early abstinence. Eur Neuropsychopharmacol 23:1078\u20131084. https:\/\/doi.org\/10.1016\/j.euroneuro.2012.08.016","journal-title":"Eur Neuropsychopharmacol"},{"key":"1613_CR31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/bs.irn.2017.02.013","volume":"135","author":"W Zhu","year":"2017","unstructured":"Zhu W, Zhang Y, Huang Y, Lu L (2017) Chinese herbal medicine for the treatment of drug addiction. Int Rev Neurobiol 135:279\u2013295. https:\/\/doi.org\/10.1016\/bs.irn.2017.02.013","journal-title":"Int Rev Neurobiol"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-023-01613-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-023-01613-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-023-01613-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T16:44:07Z","timestamp":1709916247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-023-01613-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["1613"],"URL":"https:\/\/doi.org\/10.1007\/s00406-023-01613-x","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,5]]},"assertion":[{"value":"4 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Ethics Committee at the Second Xiangya Hospital of Central South University, China.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients provided written informed consent prior to their participation, in accordance with the Declaration of Helsinki and subsequent revisions.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have approved the manuscript in its current form.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}